These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11524260)

  • 1. Use of interleukin-11 after autologous stem cell transplant: report of three cases and a very brief review of the literature.
    Borbolla JR; López-Hernández MA; De Diego J; González-Avante M; Trueba E; Collados MT
    Haematologica; 2001 Aug; 86(8):891-2. PubMed ID: 11524260
    [No Abstract]   [Full Text] [Related]  

  • 2. Refractory thrombocytopenia due to anti-PLA1 antibodies following autologous peripheral blood stem cell transplantation: case report and review of literature.
    Roy V; Verfaillie CM
    Bone Marrow Transplant; 1996 Jan; 17(1):115-7. PubMed ID: 8673043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of recombinant human interleukin 11 on the platelet after hematopoietic stem cell transplantation in patients with leukemia].
    Xu YJ; Chen FP; Li XL; Zhao XL; He Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):433-6. PubMed ID: 17611320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reticulated platelet counts correlate with treatment response in patients with idiopathic thrombocytopenic purpura and help identify the complex causes of thrombocytopenia in patients after allogeneic hematopoietic stem cell transplantation.
    Thomas-Kaskel AK; Mattern D; Köhler G; Finke J; Behringer D
    Cytometry B Clin Cytom; 2007 Jul; 72(4):241-8. PubMed ID: 17266149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of thrombopoiesis kinetics by measurement of reticulated platelets and CD34(+) cell subsets in patients with solid tumors following high dose chemotherapy and autologous peripheral blood progenitor cell support.
    Consolini R; Calleri A; Bengala C; Legitimo A; Conte PF
    Haematologica; 2001 Sep; 86(9):959-64. PubMed ID: 11532624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-overload after autologous hematopoietic cell transplantation.
    Majhail NS; DeFor TE; Lazarus HM; Burns LJ
    Leuk Res; 2009 Apr; 33(4):578-9. PubMed ID: 18632150
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover.
    Yamazaki R; Kuwana M; Mori T; Okazaki Y; Kawakami Y; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2006 Sep; 38(5):377-84. PubMed ID: 16915226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between high interleukin-6 levels and adverse outcome after autologous haemopoietic stem cell transplantation.
    Tegg EM; Griffiths AE; Lowenthal RM; Tuck DM; Harrup R; Marsden KA; Jupe DM; Ragg S; Matthews JP
    Bone Marrow Transplant; 2001 Nov; 28(10):929-33. PubMed ID: 11753546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].
    Wang XY; Feng FY; Song ST; Wang HQ; Zhang MH; Liu J; Liu XY; Xu LG; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):373-6. PubMed ID: 16117903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune disease after autologous hematopoietic stem cell transplantation.
    Bohgaki T; Atsumi T; Koike T
    Autoimmun Rev; 2008 Jan; 7(3):198-203. PubMed ID: 18190878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis.
    Ghalib R; Levine C; Hassan M; McClelland T; Goss J; Stribling R; Seu P; Patt YZ
    Hepatology; 2003 May; 37(5):1165-71. PubMed ID: 12717398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune thrombocytopenia and neutropenia after autologous peripheral blood stem cell transplantation.
    Wahid FS; Cheong SK; Sivagengei K
    Acta Haematol; 2002; 107(4):237-8. PubMed ID: 12053154
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant interleukin-11 for chemotherapy-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Jul; 40(1032):77-8. PubMed ID: 9706284
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose lenograstim to enhance engraftment after autologous stem cell transplantation: a prospective randomized evaluation of two different fixed doses.
    Suh C; Kim HJ; Kim SH; Kim S; Lee SJ; Lee YS; Kim EK; Kim SB; Lee JS; Kim MW; Kim K; Yoon SS
    Transfusion; 2004 Apr; 44(4):533-8. PubMed ID: 15043569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
    Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: failure to engraft after autologous stem cell transplantation: possible therapeutic role of cyclosporine.
    Kamble RT; Sethi S; Selby GB
    Biol Blood Marrow Transplant; 2005 Jan; 11(1):74. PubMed ID: 15625547
    [No Abstract]   [Full Text] [Related]  

  • 18. rhIL-11 for the prevention of dose-limiting chemotherapy-induced thrombocytopenia.
    Kurzrock R
    Oncology (Williston Park); 2000 Sep; 14(9 Suppl 8):9-11. PubMed ID: 11033833
    [No Abstract]   [Full Text] [Related]  

  • 19. Stem cell transplantation and hematopoietic growth factors.
    Richard S; Schuster MW
    Curr Hematol Rep; 2002 Nov; 1(2):103-9. PubMed ID: 12901131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.